Pennsylvania Family Sold Counterfeit Pills on the Dark Webby DARKNETGUIDEBOOK
The case of Hadja Franklin, 55, Tanziludin Bangurah, 52, and their child, Nabyunissa Bangoura, 34, shines a light on the dark underworld of counterfeit pharmaceuticals. Operating under the alias "MonPham," this family trio ran a sophisticated operation from their Pennsylvania home, manufacturing fake oxycodone and Xanax and distributing them through the hidden channels of the dark web.
Authorities began their investigation into MonPham in the fall of 2021, with the FBI, USPIS, and FDA-OCI joining forces to uncover the extent of their illicit activities. Delving into various dark web markets and communication platforms like Wickr, they discovered a web of interconnected accounts, all linked to the same vendor. Through meticulous undercover work, agents made several purchases, revealing the scope of MonPham's operations. The trail of bitcoin transactions led investigators to an undisclosed exchange, where they traced activity back to an IP address associated with Bangurah. Surveillance eventually led to a crucial breakthrough when Bangurah was observed dropping off a package at a USPS collection box, containing counterfeit oxycodone pills. Further searches of their residence uncovered a fully equipped pill production laboratory, complete with commercial-grade machinery and materials.
Conversations recovered from electronic devices shed light on the methods employed by the family, including the use of dangerous substances like fentanyl in their production process. Detailed sales records revealed the staggering extent of their operation, with thousands of counterfeit pills sold to unsuspecting buyers. In March 2024, the defendants pleaded guilty to conspiracy charges, underscoring the severity of their crimes. This case serves as a stark reminder of the dangers posed by illicit pharmaceuticals and the ongoing battle against dark web drug trafficking.